Neil Abdollahian, MS, MBA Vice President, Corporate Development Trius Therapeutics |
|
Rosemarie Aurigemma, Ph.D. Chief, Drug Development Section; Office of Biodefense Research Affairs DMID, NIAID, NIH |
|
Yuan-Hua Ding Senior Director, External R&D Innovation Pfizer |
|
Michael N. Dudley, Pharm.D., FCCP, FIDSA Senior VP, Research & Development and Chief Scientific Officer Rempex Pharmaceuticals |
|
Danielle Drayton Chief Operating Officer BioTrends |
|
Roger Echols Principal Member ID3C - Infectious Disease Drug Development Consulting |
|
Barry Eisenstein, M.D., FACP, FIDSA, FAAM Senior Vice President, Scientific Affairs Cubist Pharmaceuticals |
|
Prabhavathi Fernandes, Ph.D. Founder, President and Chief Executive Officer Cempra Pharmaceuticals |
|
Robert Guidos Vice President, Public Policy & Govt. Relations Infectious Diseases Society of America (IDSA) |
|
Chau Q. Khuong Private Equity Principal OrbiMed Advisors |
|
Nicholas Landekic President and Chief Executive Officer PolyMedix |
|
Joseph Larsen, Ph.D. Chief, Broad Spectrum Antimicrobials (BSA) Program; Division of CBRN Countermeasures DHHS/ASPR/BARDA |
|
Mark Leuchtenberger President and Chief Executive Officer Rib-X Pharmaceuticals |
|
Stjohn McGrath Executive Director Bristol Myers Squibb |
|
Kush M. Parmar, MD, Ph.D. Principal 5AM Ventures |
|
Brad Prosek Senior Director, Corporate Development Cubist Pharmaceuticals |
|
Brad Spellberg, M.D., FIDSA, FACP Associate Professor, Medicine Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
|
Joyce Sutcliffe Senior Vice President, Biology Tetraphase Pharmaceuticals |
|
Fred C. Tenover, Ph.D., D(ABMM), F(AAM), F(IDSA) Executive Director, Scientific Affairs Cepheid |
|
Marcel Tigges, Ph.D. Chief Scientific Officer BioVersys AG |
|
ADVISORY BOARD MEMBERS |
|
Yuan-Hua Ding Senior Director, External R&D Innovation Pfizer |
|
Roger Echols Principal Member ID3C - Infectious Disease Drug Development Consulting |
|
Barry Hafkin Chief Medical Officer Affinium Pharmaceuticals |
|
David Harper Chief Scientific Officer AmpliPhi Biosciences Corporation |
|
Jon Kaiser Chief Executive Officer K-PAX Pharmaceuticals |
|
Laurenz Kellenberger Chief Scientific Officer Basilea Pharmaceutica |
|
Malcolm Kendall President and Chief Executive Officer Indel Therapeutics |
|
Dennis Molnar Vice President, Corporate Development Paratek Pharmaceuticals |
|
Rodger Novak Head Infectious Disease TSU Global R&D Sanofi Aventis |
|
Neil Ryder Executive Director, Infectious Diseases Novartis Institutes for BioMedical Research |
|
Glenn Tillotson Senior Vice President, Medical Affairs Optimer Pharmaceuticals |